AU2004298313A1 - Use of gaboxadol for treating insomnia - Google Patents

Use of gaboxadol for treating insomnia Download PDF

Info

Publication number
AU2004298313A1
AU2004298313A1 AU2004298313A AU2004298313A AU2004298313A1 AU 2004298313 A1 AU2004298313 A1 AU 2004298313A1 AU 2004298313 A AU2004298313 A AU 2004298313A AU 2004298313 A AU2004298313 A AU 2004298313A AU 2004298313 A1 AU2004298313 A1 AU 2004298313A1
Authority
AU
Australia
Prior art keywords
gaboxadol
insomnia
treatment
oral dose
dose form
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2004298313A
Other languages
English (en)
Inventor
Bjarke Ebert
Jonas Lundahl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
H Lundbeck AS
Original Assignee
H Lundbeck AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34684447&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2004298313(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by H Lundbeck AS filed Critical H Lundbeck AS
Publication of AU2004298313A1 publication Critical patent/AU2004298313A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/423—Oxazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
AU2004298313A 2003-12-18 2004-12-14 Use of gaboxadol for treating insomnia Abandoned AU2004298313A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKDKPA200301877 2003-12-18
DKPA200301877 2003-12-18
PCT/DK2004/000861 WO2005058313A1 (en) 2003-12-18 2004-12-14 Use of gaboxadol for treating insomnia

Publications (1)

Publication Number Publication Date
AU2004298313A1 true AU2004298313A1 (en) 2005-06-30

Family

ID=34684447

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2004298313A Abandoned AU2004298313A1 (en) 2003-12-18 2004-12-14 Use of gaboxadol for treating insomnia

Country Status (17)

Country Link
EP (1) EP1720547A1 (pt)
JP (1) JP2007515415A (pt)
KR (1) KR20060103335A (pt)
CN (1) CN1893942A (pt)
AR (1) AR047154A1 (pt)
AU (1) AU2004298313A1 (pt)
BR (1) BRPI0415893A (pt)
CA (1) CA2550610A1 (pt)
EA (1) EA200600989A1 (pt)
IL (1) IL176239A0 (pt)
IS (1) IS8390A (pt)
MX (1) MXPA06006685A (pt)
NO (1) NO20063320L (pt)
SG (1) SG133601A1 (pt)
TW (1) TW200528098A (pt)
WO (1) WO2005058313A1 (pt)
ZA (1) ZA200602762B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0402118D0 (en) 2004-01-30 2004-03-03 Merck Sharp & Dohme Polymorphic forms of a GABAA agonist
WO2006118897A1 (en) * 2005-04-29 2006-11-09 H.Lundbeck A/S Acid and base salt forms of gaboxadol
MX2020002741A (es) * 2017-09-12 2020-07-21 Ovid Therapeutics Inc Uso de gaboxadol en el tratamiento de narcolepsia.
EP3833351A4 (en) 2018-09-20 2021-10-13 Ovid Therapeutics Inc. USE OF GABOXADOL TO TREAT TOURETTE SYNDROME, TICKS, AND STUTTERS
CN113423399A (zh) * 2018-12-17 2021-09-21 奥维德医疗公司 加波沙朵用于治疗非24小时睡眠-觉醒障碍的用途
IL293924A (en) 2019-12-18 2022-08-01 Ovid Therapeutics Inc Goxadol for medical treatment in 1p36 deletion syndrome

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19525598C2 (de) * 1995-07-13 1997-09-25 Max Planck Gesellschaft Schlafmittel
AU2002338855B2 (en) * 2001-05-21 2007-08-16 H. Lundbeck A/S Granular preparations of gaboxadol

Also Published As

Publication number Publication date
EA200600989A1 (ru) 2006-10-27
CA2550610A1 (en) 2005-06-30
MXPA06006685A (es) 2006-08-23
AR047154A1 (es) 2006-01-11
NO20063320L (no) 2006-07-18
BRPI0415893A (pt) 2007-01-09
IS8390A (is) 2006-03-30
EP1720547A1 (en) 2006-11-15
JP2007515415A (ja) 2007-06-14
IL176239A0 (en) 2006-10-05
ZA200602762B (en) 2007-06-27
TW200528098A (en) 2005-09-01
CN1893942A (zh) 2007-01-10
KR20060103335A (ko) 2006-09-28
SG133601A1 (en) 2007-07-30
WO2005058313A1 (en) 2005-06-30

Similar Documents

Publication Publication Date Title
AU723954B2 (en) Non-allosteric gabaA agonists for treating sleep disorders
US20080269278A1 (en) Treatment of Impaired Respiratory Function with Gaboxadol
HU217136B (hu) Riluzol alkalmazása Parkinson-kór és Parkinson-szindrómák kezelésére szolgáló gyógyszerkészítmények előállítására
EP2717698A1 (en) Antihistamines combined with dietary supplements for improved health
US20050137222A1 (en) Treatment of insomnia in human patients
AU2004298313A1 (en) Use of gaboxadol for treating insomnia
JP4394686B2 (ja) 唾液分泌促進用医薬組成物およびその使用
JP2003511410A (ja) 肥満症の治療のためのモルホリノール誘導体
US5414005A (en) Methods and articles of manufacture for the treatment of nicotine withdrawal and as an aid in smoking cessation
CA2572302A1 (en) Treatment of neuropathic pain, fibromyalgia or rheumatoid arthritis
JP2007515415A6 (ja) 不眠症の治療にガボクサドールを使用する方法
JP6959478B1 (ja) ポルフィリン症の予防又は治療剤
JPH0196131A (ja) 睡眠障害および鬱病を治療するためのある種の化合物の使用
EP1611901B1 (en) Preventive or remedy for teeth grinding
Richards et al. (312/759): ALGRX 4975 reduces pain of acute lateral epicondylitis: Preliminary results from a randomized, double-blind, placebo-controlled, phase II multicenter clinical trial
AU736514B2 (en) Non-allosteric gabaa agonists for treating sleep disorders
Weber et al. (312/776): Efficacy and safety of tapentadol HCl in patients with pain after bunionectomy
JP2022529290A (ja) 呼吸性不整脈を処置するための方法および組成物
Alkhamesi et al. (312/756): Aerosolized bupivacaine reduces post-laparoscopic pain: A randomized controlled double blinded clinical trial
Secaucus D11-Non-Opioid Analgesics: Other
Backonja et al. (312/745): Gabapentin exposure and pain reduction in patients with postherpetic neuralgia: analysis of a phase 2a randomized, double-blind, placebo controlled study of neurontin and XP13512

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application